# Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

> **NCT01842256** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 24 (actual)

## Conditions studied

- Essential Hypertension
- Hyperlipidemia

## Interventions

- **DRUG:** Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg
- **DRUG:** atorvastatin 40mg

## Key facts

- **NCT ID:** NCT01842256
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842256, "Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01842256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*